코로나19가 기업의 일터 환경을 급속도로 바꾼 지난 시간동안 HRD 담당자들은 조직의 지속가능한 학 습과 성장을 위해 노력해왔다. 특히 빅데이터, 인공지능, 증강현실, 머신러닝 등 디지털 기술의 발달로 조 직 내 일하는 방식이 변화함에 따라 나타나는 다양한 현상과 문제를 해결하기 위해 힘써오고 있다. 하지 만 코로나19로 인한 변화가 단순히 개인의 역량 개발을 하는 차원을 넘어서 조직 전반을 개발하는 차원으로 확대되었기 때문에 HRD 담당자들은 코로나19 이전의 조직과 구성원을 바라보는 인식을 벗어나 조직 문화적 관점에서 현재의 변화를 인식하고 개선해 나가야 할 필요성이 제기된다. 이에 따라 본 연구는 기 업 내 HRD 담당자들이 코로나19를 경험하면서 그들이 소속된 조직의 조직문화를 바라보는 인식이 어떻 게 변화하고 있고, 그 인식의 변화에서 느끼는 의미는 무엇인지를 탐구해 보는 것을 목적으로 한다. 이를 위해 연구 참여자가 경험한 이야기를 바탕으로 연구 주제에 관한 이야기를 재구성하여 인사이트를 탐구 하는 내러티브 연구 방법으로 살펴보고자 하였다. 목적 표집 방식으로 8인의 연구 참여자를 선정하였으며 비구조화된 심층 면담, 참여관찰, 문헌 연구 분석 등을 활용하여 조금 더 자세하고 구체적인 의미를 해석 하였다. 이에 대한 연구는 향후 조직문화를 바라보는 인식이 변화함에 따라 HRD 담당자들이 수행해야 할 다양한 역할과, 그들이 지향하고 만들어가고자 하는 조직문화 유형이 어떻게 바뀌어 가고 있는지 탐색 할 수 있을 것으로 기대한다.

Five insecticides (Acrinathrin, Dinotefuran, Emamectin benzoate, Chlorfenapyr and fluxametamide) approved for tomato cultivation were evaluated in Frankliniella occidentalis populations collected from Chungcheong province (Cheongyang, Chungju and Gongju). Leaf dip bioassay was used to evaluate resistance levels (LC50). Bioassays on Acrinathrin demonstrated higher LC50 concentration in evaluated populations. In particular, the Chungju population was 745.61 times the recommended concentration of the insecticide. Other remarkable resistance levels were recorded for the Dinotefuran with 435.06 times and 196.29 times the recommended concentrations for the populations from Chungju and Gongju, respectively. Bioassays for Emamectin benzoate, Chlorfenapyr and Fluxametamide showed low resistance to insecticides in the evaluated populations.

Yellow flower thrips (WFT), Frankliniella occidentalis is mainly controlled using chemical control methods. But the continuous use of chemical pesticides in greenhouse may contribute to development of insecticide resistance. Therefore, in this study, we evaluated the insecticidal activity of eleven insecticides against the WFT occurring in greenhouse pepper cultivation in the Gyeonggi province. The results showed no resistance in treatments with emamectin benzoate, fluxametamide, and flometoquin while high levels of resistance were recorded in treatments with acrinathrin, acetamiprid, and dinotefuran. The Anseong and Yeoju population was more resistant against spinetoram and chlorfluazuron, respectively, than populations from other regions.

As the size of the gaming market continues to grow, game engines like Unity and Unreal are constantly being developed and updated for multi-platform support. In particular, Unity divides the Render Pipeline to be used. Among them, the Universal Render Pipeline (URP) has the advantage of supporting various platforms while improving performance by reducing draw calls and batches at the same quality settings and reducing the load on the CPU and GPU. However, only limited global illumination is supported in the real-time 3D rendering area within URP, such as Baked GI and Enlighten GI, and Enlighten GI will be deprecated after 2024LST, so real-time global illumination is not available in URP, which may reduce the realism and immersion of global illumination in games or applications that use URP. The main objective of this research is to incorporate precomputed spherical harmonics into URP to enable dynamic GI updates in real-time. The approach proposed in this research is to compute the coefficients of spherical harmonics offline and then run them within the URP rendering pipeline, where work exists to effectively simulate dynamic lighting conditions. To demonstrate this, experiments were conducted by changing the rotation and color of the lights, and a comparative analysis was performed to demonstrate the effectiveness of the theory proposed in this work.

Following the previous study, the toxicity of a single subcutaneous administration of the Thyrokitty injection (I-131) and the side effects that may occur at therapeutic doses were confirmed. The Thyrokitty injection (I-131) was administered subcutaneously once at a dose of 0, 2.0, 6.0, and 18.0 mCi/kg, 5 male and female rats per group, and mortality, general symptom observation, and weight measurement were performed for 2 weeks, followed by observation of autopsy findings. There were no deaths, and no statistically significant weight change was observed. Mild hair loss, fissures, and crusting were observed by general symptom observation, but it was not a toxic change related to the Thyrokitty injection (I-131). Gastric atrophy and a decrease in the size of the spleen were observed by the autopsy. As a results of single subcutaneous administration of the Thyrokitty Injection (I-131) to rats at a maximum dose of 18.0 mCi/kg, a decrease in the size of the spleen and gastric atrophy were observed as the dose of the Thyrokitty Injection (I-131) increased, which may be related to the test substance. No abnormal findings related to the Thyrokitty injection (I-131) were observed. Therefore, the approximate lethal dose of the Thyrokitty injection (I-131) was 18.0 mCi/kg or more. In addition, as reported for the treatment of feline hyperthyroidism with radioiodine (131I), side effects of the Thyrokitty injection (I-131) are expected to be extremely rare. Temporary dysphagia and fever may occur, but it will recover naturally. It should be administered with caution in cats with diseases such as urinary system, cardiovascular system, gastrointestinal system and endocrine system, especially with kidney disease. And it should not be used in cats who are pregnant, lactating, or likely. It is expected that the Thyrokitty injection (I-131) can be used for clinical treatment in Korea as a veterinary drug.

Radioiodine (131I) has been used for the treatment of feline hyperthyroidism since the 1990s in the USA and Europe, and it is recommended as the most effective treatment for feline hyperthyroidism because it has a high therapeutic effect, small side effects, and does not require anesthesia. In this study, the pharmacological properties of the Thyrokitty injection (I-131), which is being developed as a treatment for feline hyperthyroidism, using radioiodine (131I) as an active ingredient, was tested. The %cell uptake of the Thyrokitty injection (I-131) in FRTL- 5 thyroid cells was 0.410 ± 0.016%, which was about 18 times higher compared to Clone 9 hepatocytes, and it was decreased by 30.7% due to the competitive reaction with iodine (sodium iodide). In addition, the %cell growth of the FRTL-5 thyroid cells was reduced by 25.0% by treatment with the Thyrokitty injection (I-131). As a result of the tissue distribution test, the Thyrokitty injection (I-131) was distributed at the highest concentration at 0.083 hours (5 minutes) after subcutaneous administration to animals in most organs except the stomach, small intestine, large intestine, muscle and thyroid gland, and it was excreted mainly through the kidneys. The stomach and thyroid gland showed a typical distribution pattern observed when radioiodine (131I) was administered. In addition, about 78.45% of the total amount of excretion was excreted within 48 hours, of which more than 85% was excreted in urine. In conclusion, the Thyrokitty injection (I-131) has the same mechanism of action, potency, absorption, distribution, metabolism and excretion characteristics as radioiodine (131I) reported in connection with the treatment of feline hyperthyroidism. In the future, using the results of this study, it is expected that the Thyrokitty (I-131) could be safely used in the clinical treatment of feline hyperthyroidism.

X-chromosome inactivation is one of the most complex events observed in early embryo developments. The epigenetic changes occurred in female X-chromosome is essential to compensate dosages of X-linked genes between males and females. Because of the relevance of the epigenetic process to the normal embryo developments and stem cell studies, X-chromosome inactivation has been focused intensively for last 10 years. Initiation and regulation of the process is managed by diverse factors. Especially, proteins and non-coding RNAs encoded in X-chromosome inactivation center, and a couple of transcription factors have been reported to regulate the event. In this review, we introduce the reported factors, and how they regulate epigenetic inactivation of X-chromosomes.

Even though klotho deficiency in mice exhibits multiple aging-like phenotypes, studies using large animal models such as pigs, which have many similarities to humans, have been limited due to the absence of cell lines or animal models. The objective of this study was to generate homozygous klotho knockout porcine cell lines and cloned embryos. A CRISPR sgRNA specific for the klotho gene was designed and sgRNA (targeting exon 3 of klotho) and Cas9 RNPs were transfected into porcine fibroblasts. The transfected fibroblasts were then used for single cell colony formation and 9 single cell–derived colonies were established. In a T7 endonuclease I mutation assay, 5 colonies (#3, #4, #5, #7 and #9) were confirmed as mutated. These 5 colonies were subsequently analyzed by deep sequencing for determination of homozygous mutated colonies and 4 (#3, #4, #5 and #9) from 5 colonies contained homozygous modifications. Somatic cell nuclear transfer was performed to generate homozygous klotho knockout cloned embryos by using one homozygous mutation colony (#9); the cleavage and blastocyst formation rates were 72.0% and 8.3%, respectively. Two cloned embryos derived from a homozygous klotho knockout cell line (#9) were subjected to deep sequencing and they showed the same mutation pattern as the donor cell line. In conclusion, we produced homozygous klotho knockout porcine embryos cloned from genome-edited porcine fibroblasts.